For studies using QoL as the primary outcome measure it is worth bearing in mind that the inclusion of patients with low insight scores, low depression scores and high negative symptom scores will serve to increase the degree of discrepancy between patient-rated and assessor-rated QoL.
In addition, comorbid depression was more frequent in subjects belonging to the low insight group.
Depression was found to be significantly more frequent in youth with low insight (57.14%) than in youth with high insight (25%; Chi-square test; p = 0.01).
Overall, these findings suggest that the clinical presentation of children with low insight is distinct than from those with high insight, with increased disease severity, symptom severity, and the presence of comorbid conditions, particularly depression in patients with low insight.
The relationship between depression and insight is thought to be mediated by internalized stigma: insight is only associated with depression in patients who hold stigmatizing beliefs about mental illness [ 12, 13].
Table 3 shows that patient-rated (LQOLP) quality of life was statistically determined by depression (CDSS), insight (BIS), non-neurological side effect score (ANNSERS) and adherence rating (Kemp).> In the model, depression explains 34% of the variance in score on the LQOLP, insight a further 5.6%, non-neurological side effects 4%, and adherence rating a further 4.6% each.
We assessed 1,001 consecutive OCD patients, using instruments designed to evaluate the frequency/severity of OC symptoms, tics, anxiety, depression, level of insight and presence/severity of sensory phenomena.
The chronic CORT model in mice that displays hallmark characteristics of anxiety and depression provides an insight into understanding the changes in overall sleep architecture that occur under pathological conditions.
This study aimed at investigating the relations among the psychological factors alexithymia, self-reflection, insight, depression, anxiety; demographic variables; and aspects of the impacts of the disorder on these patients' lives, such as severity of symptoms and quality of life in migraine sufferers as compared to a group of matched controls.
However, this lack of "purity" in the control group along with the significant difference of averages in all variables (alexithymia, self-reflection, insight, depression, anxiety and quality of life) reinforces the distinction between migraine sufferers and non-sufferers and the importance of the assessment of those variables in migraine patients.
